Compare, Analyse Suven Life Sciences with ADCOCK INGRAM HOLDINGS LTD. - S. Africa - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SUVEN LIFE SCIENCES vs ADCOCK INGRAM (S. Africa) - Comparison Results

ADCOCK INGRAM (S. Africa)
   Change

Adcock Ingram is a leading South African pharmaceutical manufacturer, marketer and distributor. The company occupies 10% share of the private pharmaceutical market in South Africa with a strong presence in over-the-counter (OTC) brands. Adcock is als... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 SUVEN LIFE SCIENCES   ADCOCK INGRAM
EQUITY SHARE DATA
    SUVEN LIFE SCIENCES
Mar-19
ADCOCK INGRAM
Jun-14
SUVEN LIFE SCIENCES/
ADCOCK INGRAM
5-Yr Chart
Click to enlarge
High Rs338352-   
Low Rs169254-   
Sales per share (Unadj.) Rs52.1104.8-  
Earnings per share (Unadj.) Rs6.8-26.4-  
Cash flow per share (Unadj.) Rs8.6-21.9-  
Dividends per share (Unadj.) Rs1.500-  
Dividend yield (eoy) %0.60-  
Book value per share (Unadj.) Rs65.382.3-  
Shares outstanding (eoy) m127.28168.78-   
Bonus/Rights/Conversions ---  
Price / Sales ratio x4.92.9 168.1%   
Avg P/E ratio x37.1-11.5 -323.3%  
P/CF ratio (eoy) x29.6-13.9 -213.5%  
Price / Book Value ratio x3.93.7 105.3%  
Dividend payout %22.00-   
Avg Mkt Cap Rs m32,27251,185 63.0%   
No. of employees `0001.14.3 25.2%   
Total wages/salary Rs m6613,212 20.6%   
Avg. sales/employee Rs Th6,132.24,120.8 148.8%   
Avg. wages/employee Rs Th611.1748.3 81.7%   
Avg. net profit/employee Rs Th803.5-1,038.3 -77.4%   
INCOME DATA
Net Sales Rs m6,63517,690 37.5%  
Other income Rs m242124 195.6%   
Total revenues Rs m6,87717,814 38.6%   
Gross profit Rs m1,604-3,066 -52.3%  
Depreciation Rs m221764 29.0%   
Interest Rs m38479 7.9%   
Profit before tax Rs m1,587-4,184 -37.9%   
Minority Interest Rs m0-12 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m718261 274.6%   
Profit after tax Rs m869-4,458 -19.5%  
Gross profit margin %24.2-17.3 -139.5%  
Effective tax rate %45.2-6.2 -723.9%   
Net profit margin %13.1-25.2 -52.0%  
BALANCE SHEET DATA
Current assets Rs m6,23212,957 48.1%   
Current liabilities Rs m1,4907,290 20.4%   
Net working cap to sales %71.532.0 223.1%  
Current ratio x4.21.8 235.3%  
Inventory Days Days86111 77.9%  
Debtors Days Days83124 66.6%  
Net fixed assets Rs m4,0437,552 53.5%   
Share capital Rs m12782 155.0%   
"Free" reserves Rs m8,1830-   
Net worth Rs m8,31013,885 59.8%   
Long term debt Rs m184,879 0.4%   
Total assets Rs m10,38926,230 39.6%  
Interest coverage x43.1-7.7 -557.5%   
Debt to equity ratio x00.4 0.6%  
Sales to assets ratio x0.60.7 94.7%   
Return on assets %8.7-15.2 -57.6%  
Return on equity %10.5-32.1 -32.6%  
Return on capital %19.5-19.8 -98.5%  
Exports to sales %00-   
Imports to sales %00-   
Net fx Rs m3,8220-   
CASH FLOW
From Operations Rs m3561,510 23.5%  
From Investments Rs m-279-464 60.1%  
From Financial Activity Rs m-2254,428 -5.1%  
Net Cashflow Rs m-1485,475 -2.7%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ADCOCK INGRAM (S. Africa) is South Africa Rand. All data has been converted at 4.86 Rs / ZAR

Compare SUVEN LIFE SCIENCES With: ACTAVIS (US)  MYLAN (US)  TEVA PHARMA (Israel)  

Compare SUVEN LIFE SCIENCES With: IPCA LABS  DIVIS LABORATORIES  ALEMBIC PHARMA  GLENMARK PHARMA  NEULAND LABS  



Today's Market

Nifty is Weak but Smallcaps Can Outperform(Momentum Moves)

The market see-sawed during the week with both the bulls and bears swinging it out. But in the end, it was the bears who won. The Nifty ended the day, the week, and the month at 14,529.15.

Related Views On News

SUVEN LIFESCIENCES Announces Quarterly Results (1QFY20); Net Profit Up 47.2% (Quarterly Result Update)

Aug 28, 2019 | Updated on Aug 28, 2019

For the quarter ended June 2019, SUVEN LIFESCIENCES has posted a net profit of Rs 572 m (up 47.2% YoY). Sales on the other hand came in at Rs 2 bn (up 3.8% YoY). Read on for a complete analysis of SUVEN LIFESCIENCES's quarterly results.

SUVEN LIFESCIENCES 2018-19 Annual Report Analysis (Annual Result Update)

Jul 22, 2019 | Updated on Jul 22, 2019

Here's an analysis of the annual report of SUVEN LIFESCIENCES for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of SUVEN LIFESCIENCES. Also includes updates on the valuation of SUVEN LIFESCIENCES.

SUVEN LIFESCIENCES Announces Quarterly Results (4QFY19); Net Profit Up 8.7% (Quarterly Result Update)

May 27, 2019 | Updated on May 27, 2019

For the quarter ended March 2019, SUVEN LIFESCIENCES has posted a net profit of Rs 680 m (up 8.7% YoY). Sales on the other hand came in at Rs 3 bn (up 18.5% YoY). Read on for a complete analysis of SUVEN LIFESCIENCES's quarterly results.

More Views on News

Most Popular

It's the Beginning of a New Bull Phase in Smallcaps (Profit Hunter)

Feb 24, 2021

Last time the smallcap index crossed 19k a big correction followed. Here's what makes it different this time.

Intraday Trading for a Living (Fast Profits Daily)

Feb 15, 2021

In this video, I'll cover your queries on intraday trading and also share my view on how to decide stop losses and target prices.

Top 5 Stocks Mutual Funds Bought and Sold in January 2021 (Sector Info)

Feb 16, 2021

A look at what India's top equity mutual funds bought and sold in January 2021.

I Would Recommend this Small-cap Stock Over Tesla (Profit Hunter)

Feb 16, 2021

Do you enjoy reading Tesla and Bitcoin stories? Here's a not so famous small-cap stock to profit from the rise of EVs.

More
-->

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

OUR TOP 5 IDEAS

Access Now: Eight Steps to Your Eight Figure Fortune
Are You Making One of These 15 Costly Mistakes While Investing. Learn more!
Covid-19 Proof Multibagger Stocks - Download this FREE Report Now
Free Report: The Secret to Increasing Your Trading Profits Daily!
No Guessing, No Hunches, and No Missed Trends Ever! Join Us on YouTube Now.

SUVEN LIFE SCIENCES SHARE PRICE


Feb 26, 2021 (Close)

TRACK SUVEN LIFE SCIENCES

  • Track your investment in SUVEN LIFE SCIENCES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON SUVEN LIFE SCIENCES

SUVEN LIFE SCIENCES 8-QTR ANALYSIS

COMPARE SUVEN LIFE SCIENCES WITH

FEATURED VIDEOS

Nifty is Weak but Smallcaps Can Outperform

Gold 65,000 and Silver 84,000 in 2022

How Long Before a Big Stock Market Crash

I Believe the Investment of the Year Will Be...

More Featured Videos

MARKET STATS